News Stories Pulled from Leading Newswires
Cannabis Marketing Agency Launches 420Ad.net, a Targeted Advertising Network for Cannabis Brands
CannabisPromoter.com expands its services with 420Ad.net, a dedicated advertising network allowing cannabis brands to reach highly targeted audiences ...
Astoria Bud Boutique Hosts NBA Finals Watch Party, Offers Game 6 Ticket Giveaway
Astoria Bud Boutique engages Knicks fans with a Game 5 watch party and a chance to win tickets to Game 6, blending cannabis culture with New York spor...
Optimi Health Completes First Psilocybin Export to UK for Phase 2 Clinical Trial
Optimi Health Corp. has shipped naturally derived psilocybin capsules and biomass to the UK for a Phase 2 trial, marking a key step in expanding inter...
Optimi Health Advances Ibogaine Initiative, Plans GMP-Grade Production for Research and Therapeutic Programs
Optimi Health Corp. announced progress on its Ibogaine Initiative, securing naturally derived ibogaine and planning GMP-grade production of encapsulat...
Optimi Health Completes GMP Production Run of Psilocybin Drug Product for Global Markets
Optimi Health Corp. has completed a GMP production run of 5mg psilocybin capsules, using the same formulation prescribed in Australia, with product de...
DEA to Hold Hearing on Marijuana Reclassification as Industry Awaits Key Decision
The DEA will hold a hearing in June on reclassifying marijuana under federal law, drawing interest from both sides of the legalization debate and sign...
Missouri Cannabis Regulators Prepare for Final Microbusiness License Lottery with Enhanced Oversight
Missouri regulators are launching a statewide outreach effort ahead of the final lottery for 77 microbusiness marijuana permits, implementing policy c...
Optimi Health Welcomes Australian TGA Reforms Expanding Psychedelic Therapy Access
Optimi Health praises Australia's updated psilocybin and MDMA prescribing rules, which broaden therapy teams and settings, potentially accelerating ad...
Australia’s TGA Updates Psychedelic Therapy Framework, Optimi Health Welcomes Broader Access
Optimi Health Corp. praised Australia’s TGA final recommendations that expand eligible therapy teams and treatment settings for psilocybin and MDMA, p...
Massachusetts Regulators to Test THC Label Accuracy, Boosting Industry Confidence
Massachusetts cannabis regulators will test whether THC levels on product labels match actual content, a move that could increase consumer trust and b...
NuggMD Expands to UK, Integrates Stripe to Streamline Medical Cannabis Payments
NuggMD launches in the UK and integrates Stripe for seamless payments, enhancing access for medical cannabis patients.
Jupiter Neurosciences Raises $2 Million in Registered Direct Offering
Jupiter Neurosciences closed a $2 million registered direct offering to fund its CNS pipeline, including a Phase IIa trial for Parkinson's disease and...